| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > CeMAP Training and Company Sponsored Courses |
|
Digg It - CeMAP Training and Company Sponsored Courses
CeMAP training is an excellent career boosting qualification, offering CeMAP qualified individuals greater earning potential, increased promotion opportunities and enhanced job satisfa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ction. Because of this, in the past, some employers have paid for their staff to undertake the CeMAP training courses. In these cases, the employers have usually insisted that the empl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in yees who take advantage of these CeMAP training courses sign contracts agreeing to repay to the company in part or in full, the cost of the CeMAP training course if they leave the comp lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ny within a specified period of time. This can amount to a substantial amount of money, and the employees can find themselves tied to the employer for up to three years if they want to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe avoid the penalty. The recent trend is showing that more and more companies are now withdrawing this opportunity, instead relying on the staff members to pay for the CeMAP training t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro emselves. Our company received an e-mail recently saying that Northern Rock had now stopped providing CeMAP training to its employees. If this is the case, then this is another example ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc of a large company removing this training opportunity. So where does this trend leave employees who are looking to complete their CeMAP training? In reality, many people feel that the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi company sponsored training route, while saving costs in the short term, may actually cost the employee dearly in the longer term. The truth is that someone with the CeMAP qualificatio nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically has an excellent earning potential in the job market, and there are more and more vacancies for mortgage advisers being advertised every week. So once an individual has passed their C and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ MAP exams, the door is really open for an excellent opportunity to earn more money. When an individual has undertaken the training under the company scheme, they are typically tied to ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the company for two or three years, during which period they are also tied to the salary package that the company deems suitable. In many cases this means that the CeMAP qualified pers ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a on is now earning considerably less money than they would be able to on the open job market. When this loss of extra income is taken into account, the relatively small saving that some dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ne would make by having the company pay for the CeMAP training is greatly out weighed by the loss of extra income available once they have the CeMAP qualification. Often with company cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin raining schemes, the repayment cost can be two, three, or more times the cost that an individual would incur by enrolling in a CeMAP training course for themselves. This extra cost is tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen due to the fact that the company will usually insist on classroom training, which is inherently more expensive than a comprehensive and flexible CeMAP Home Study Course. Because of thi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel , many people are now training independently using comprehensive CeMAP training by distance learning so that they can study in their own time, at their own pace and without being tied ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o an employer once they have qualified. This means that they are then free to pursue other avenues of employment once they have their CeMAP qualification or, of course, they can seek p y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products romotion or other opportunities within their current company. The important message from all of this is that it is not necessarily a major problem if the employer does not pay for CeM . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de P training, in fact in many cases, having paid to obtain your CeMAP qualification yourself can give you greater freedom and open the door to many new and exciting opportunities that wo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ld otherwise not be available to you. For more information on flexible Home Study for CeMAP training then click on the link tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Commercial Zoning Has You Confused? Read on... The Future Of Advertising: How Crafty Marketers Are Chasing After Your Cash
|